Programmed Death Ligand 1 Expression in Laryngeal Squamous Cell Carcinomas and Prognosis

AIM: We aimed to show the immunohistochemical expression of programmed death ligand 1 (PD-L1) in laryngeal squamous cell carcinomas (SCCs). MATERIALS AND METHODS: The study includes 52 laryngeal SCC cases that underwent surgical resection. Immunohistochemical staining of PD-L1 (Clone 22C3) was appli...

Descripción completa

Detalles Bibliográficos
Autores principales: Batur, Sebnem, Kain, Zeynep Ecem, Gozen, Emine Deniz, Kepil, Nuray, Aydin, Ovgu, Comunoglu, Nil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Focus Section: Novel Therapies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672728/
https://www.ncbi.nlm.nih.gov/pubmed/33241207
http://dx.doi.org/10.1177/2632010X20964846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672728/
https://www.ncbi.nlm.nih.gov/pubmed/33241207
http://dx.doi.org/10.1177/2632010X20964846

Ejemplares similares